Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sparo Labs
St. Louis, Missouri, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Sparo Labs has developed and commercialized Wing, the first FDA-cleared over-the-counter smartphone sensor for measuring lung function, empowering patients with asthma, COPD, and cystic fibrosis to proactively manage their condition. The product is available for purchase and has demonstrated clinical utility in monitoring respiratory health[1][2][3][4].
- Therapeutic areas
- Pulmonology
- Modalities
- DeviceDigital health tool
- Industry
- Physiological Monitoring
Beyond the preview
Go deeper on Sparo Labs.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sparo Labs.